Prosecution Insights
Last updated: April 19, 2026

New York University

44 pending office actions

Portfolio Summary

44
Total Pending OAs
15
Final Rejections
29
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19067406 Doped Organic Semiconductors and Methods of Making the Same NGUYEN, HAIDUNG D 1761 Non-Final OA Feb 28, 2025
18948295 SYSTEMS AND METHODS FOR IMAGE BASED MAPPING AND NAVIGATION DIZON, EDWARD ANDREW IZON 3663 Non-Final OA Nov 14, 2024
18942745 SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR DIRECT VISUALIZATION WITH POWER SPECTRUM REGULARIZATION JASANI, ASHISH SHIRISH 3798 Non-Final OA Nov 10, 2024
18796218 USE OF IGF-2 RECEPTOR AGONIST LIGANDS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM KRISHNAN, GANAPATHY 1693 Non-Final OA Aug 06, 2024
18705788 CLOSED-LOOP NEURAL INTERFACE FOR PAIN CONTROL STICE, PAULA J 3796 Non-Final OA Apr 29, 2024
18690480 SYSTEM AND METHOD FOR STEREOSCOPIC IMAGE GENERATION BRUTUS, JOEL F 3797 Non-Final OA Mar 08, 2024
18439617 Topological Qubit Architecture Based on Josephson Junction Fabricated on Two-Dimensional Electron Gases KRAIG, WILLIAM F 2896 Final Rejection Feb 12, 2024
18434053 SYSTEMS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING A LANGUAGE MODEL POPULATION SIMULATOR ALBERTALLI, BRIAN LOUIS 2656 Non-Final OA Feb 06, 2024
18419542 TRACKING SPARSE OBJECTS AND PEOPLE IN LARGE SCALE ENVIRONMENTS CHANG, DANIEL CHEOLJIN 2669 Non-Final OA Jan 22, 2024
18575905 SYSTEMS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FACILITATING DEPLOYMENT OF ANTIDEPRESSANTS AND OTHER PRESCRIPTION DRUGS HUYNH, EMILY 3683 Final Rejection Jan 02, 2024
18487767 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AUTOIMMUNE INDUCED CARDIAC LONG QT SYNDROME WEIDNER, ADAM M 1675 Non-Final OA Oct 16, 2023
18555363 Bone Marrow on a Chip MUTREJA, JYOTI NAGPAUL 1798 Non-Final OA Oct 13, 2023
18339773 USES OF ORAI1-SPECIFIC CALCIUM CHANNELS IN TREATMENT OF ORAL CANCER CHAO, ALLEN 1622 Non-Final OA Jun 22, 2023
18257504 CHEMICALLY MODIFIED CRISPR-CAS13 GUIDE RNAS KONOPKA, CATHERINE ANNE 1635 Non-Final OA Jun 14, 2023
18318957 MICROFLUIDIC FLOW CONTROL RAEVIS, ROBERT R 2855 Final Rejection May 17, 2023
18251384 ENHANCEMENT OF PREDICTABLE AND TEMPLATE-FREE GENE EDITING BY THE ASSOCIATION OF CAS WITH DNA POLYMERASE TATGE, LEXUS MARC 1637 Non-Final OA May 01, 2023
18308530 ENHANCEMENT OF SAFETY AND PRECISION FOR CRISPR-Cas INDUCED GENE EDITING BY VARIANTS OF DNA POLYMERASE USING CAS-PLUS VARIANTS GROOMS, TIFFANY NICOLE 1637 Non-Final OA Apr 27, 2023
18135990 SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR SEPARATING FAT AND WATER IN MAGNETIC RESONANCE IMAGING USING FREQUENCY SWEEP RADIOFREQUENCY SATURATION PULSES CLARKE, ADAM S 2858 Non-Final OA Apr 18, 2023
18297160 NASAL MOLDING DEVICE JAMIALAHMADI, MAJID 3771 Final Rejection Apr 07, 2023
18247155 JOINT DISTRACTION DEVICE HANNA, SAMUEL SALEEB 3775 Final Rejection Mar 29, 2023
18028477 VARIANT STAPHYLOCOCCUS AUREUS LUKA AND LUKB POLYPEPTIDES AND VACCINE COMPOSITIONS OGUNBIYI, OLUWATOSIN A 1645 Final Rejection Mar 24, 2023
18186698 TARGETING SUCNR1 TO REDUCE NEUROINFLAMMATION RODRIGUEZ, RAYNA B 1628 Non-Final OA Mar 20, 2023
18159675 LIPOSOMES ENCAPSULATING ADENOSINE SHOMER, ISAAC 1612 Final Rejection Jan 25, 2023
18101105 DIGITAL WITNESS SYSTEMS AND METHODS FOR AUTHENTICATING AND CONFIRMING THE INTEGRITY OF A DIGITAL ARTIFACT JOHNSON, AMY COHEN 2400 Non-Final OA Jan 24, 2023
18153727 STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF ZEMAN, ROBERT A 1645 Non-Final OA Jan 12, 2023
18000772 MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE SALVOZA, M FRANCO G 1672 Non-Final OA Dec 05, 2022
17997467 COMPOSITIONS AND METHODS FOR IDENTIFICATION OF ZINC FINGERS FLINDERS, JEREMY C 1684 Non-Final OA Oct 28, 2022
17937630 THERAPEUTIC MUSK ANTIBODIES YAO, LEI 1642 Final Rejection Oct 03, 2022
17818968 COMPOSITIONS AND METHODS FOR IMPROVING PLANT NITROGEN UTILIZATION EFFICIENCY (NUE) AND INCREASING PLANT BIOMASS MCWILLIAMS, KELSEY LYNN 1663 Final Rejection Aug 10, 2022
17816152 Tumor-on-a-chip MYERS, CARLA J 1682 Non-Final OA Jul 29, 2022
17789047 THE COMBINATION OF CYCLIN DEPENDENT KINASE 7 INHIBITOR AND IMMUNOTHERAPY FOR TREATMENT OF CANCER SCHMIDT, IZABELA MARIA 1621 Final Rejection Jun 24, 2022
17736535 Screening and Assessment of Carcinomas HALVORSON, MARK 1646 Final Rejection May 04, 2022
17705762 DEPOLYMERIZATION AND VALORIZATION OF A BIOPOLYMER CHO, DAVID H 1693 Non-Final OA Mar 28, 2022
17642471 HIGH-GAIN AMORPHOUS SELENIUM PHOTOMULTIPLIER YECHURI, SITARAMARAO S 2893 Non-Final OA Mar 11, 2022
17680716 Photovoltaic Devices and Methods of Making the Same MALLEY JR., DANIEL PATRICK 1726 Final Rejection Feb 25, 2022
17637427 TARGETING SLC38A2 IN PANCREATIC CANCER ANGELL, JON E 1637 Final Rejection Feb 22, 2022
17592169 BIOMIMETIC TISSUE AND METHOD OF USE THEREOF ARNOLD, ERNST V 1613 Non-Final OA Feb 03, 2022
17625326 TUMOR IMMUNOTHERAPY USING SINDBIS VIRAL VECTORS AND AGONIST MONOCLONAL ANTIBODIES HALVORSON, MARK 1646 Final Rejection Jan 06, 2022
17608103 METHODS AND COMPOSITIONS FOR SENSITIZING CANCER CELLS TO DRUG-INDUCED APOPTOSIS BAKSHI, PANCHAM 1623 Final Rejection Nov 01, 2021
17432750 PHOTOSWITCHABLE PROTACS AND SYNTHESIS AND USES THEREOF BAUER, NICOLA MARIA 1621 Non-Final OA Aug 20, 2021
17371613 GRAPHITIC CARBON NITRIDE MATERIALS AND METHODS OF MAKING AND USE THEREOF ALEJANDRO, RAYMOND 1752 Non-Final OA Jul 09, 2021
17184758 PREVENTING AND TREATING AMYLOID- BETA DEPOSITION BY STIMULATION OF INNATE IMMUNITY BALLARD, KIMBERLY 1675 Non-Final OA Feb 25, 2021
17152463 ADENO-ASSOCIATED VIRAL VECTOR, COMPOSITIONS, METHODS OF PROMOTING MUSCLE REGENERATION, AND TREATMENT METHODS NICOL, ALEXANDER W 1634 Non-Final OA Jan 19, 2021
17059464 Compounds and Methods for Treating Bacterial Infections SHTERENGARTS, SAMANTHA L 1623 Non-Final OA Nov 29, 2020

Managing New York University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month